Chemcon Speciality Chemicals Limited

NSE:CHEMCON.NS

233.34 (INR) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 525.981455.214595.913529.807751.93793.271790.826764.712579.195894.114887.631495.402612.406572.054712.181648.064615.37456.656510.104557.313653.407772.592
Cost of Revenue 316.198333.624485.764410.293534.543598.947535.91489.58349.903382.044626.439190.034305.152274.943527.909310.867257.105248.05463.319317.981352.011445.03
Gross Profit 209.783121.59110.149119.514217.387194.324254.916275.132229.292512.07261.192305.368307.254297.111184.272337.197358.265208.60646.785239.332301.396327.562
Gross Profit Ratio 0.3990.2670.1850.2260.2890.2450.3220.360.3960.5730.2940.6160.5020.5190.2590.520.5820.4570.0920.4290.4610.424
Reseach & Development Expenses 0000000.995000000000000000
General & Administrative Expenses 0000000000000000000000
Selling & Marketing Expenses 0000000000000000000000
SG&A 77.20575.72591.45381.89683.93240.02464.12590.83584.16456.4354.61449.50847.64475.76297.70546.37437.36631.9537.72331.2334.71538.147
Other Expenses 037.64633.3833.42330.32435.87128.85844.58532.88526.818-65.04823.31122.50619.419-5.34112.1511.4193.438-19.6747.77900
Operating Expenses 77.20575.72591.45381.896160.071143.403136.819161.59153.951195.795-3.634147.593132.916133.656-10.892122.913138.90582.348-78.842116.051110.128115.871
Operating Income 59.70545.86518.69637.61887.63950.922146.955158.126108.226316.275264.826157.776179.338163.455195.164214.284220.779126.258125.627123.281183.886205.636
Operating Income Ratio 0.1140.1010.0310.0710.1170.0640.1860.2070.1870.3540.2980.3180.2930.2860.2740.3310.3590.2760.2460.2210.2810.266
Total Other Income Expenses Net 25.61927.795-64.00522.999-86.809-74.276-36.841-73.505-74.28525.174-59.999-75.82420.96817.149-34.1195.807-10.415-7.7384.52-1.299-4.375-90.864
Income Before Tax 85.32473.6641.55160.61780.38380.025142.071152.233105.761341.449284.007180.037195.306180.604213.001220.091208.945118.52130.147121.982179.511198.551
Income Before Tax Ratio 0.1620.1620.070.1140.1070.1010.180.1990.1830.3820.320.3630.3190.3160.2990.340.340.260.2550.2190.2750.257
Income Tax Expense 22.03419.97212.51916.18221.00420.94237.37138.64727.52486.87271.12445.17449.61246.47857.96955.3353.13630.1432.21429.18243.28747.998
Net Income 63.2953.68829.03244.43559.37959.083104.701113.58678.237254.577212.883134.863145.694134.126155.032164.761155.80988.3897.93392.8136.224150.553
Net Income Ratio 0.120.1180.0490.0840.0790.0740.1320.1490.1350.2850.240.2720.2380.2340.2180.2540.2530.1940.1920.1670.2080.195
EPS 1.731.470.791.211.621.612.863.12.146.955.813.683.983.664.534.54.252.412.672.534.294.74
EPS Diluted 1.731.470.791.211.621.612.863.12.146.955.813.683.983.664.534.54.252.412.672.534.294.74
EBITDA 120.112108.7877.22596.83113.584113.004169.509179.488128.767362.352301.796196.596211.876198.071239.482240.566234.694142.884141.82141.795194.411216.161
EBITDA Ratio 0.2280.1560.0740.120.1510.1420.2140.2350.2220.4050.340.3970.3460.3460.3350.3710.3810.3130.2780.2540.2980.28